Statistics from Altmetric.com
I took great interest in the recent article regarding the retinal pigment epithelium (RPE) transplantation by Falkner-Radler et al.1 I agree that RPE cell transplantation might be a novel therapeutic option for patients in the antivascular endothelial growth factor (anti-VEGF) era, where anti-VEGF fails to improve visual acuity. This is the case in RPE tear,2 massive subretinal haemorrhage3 or anti-VEGF non-responders.
As already stated by the authors, transplantation of an RPE cell suspension has the disadvantage of …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.